AI In Oncology Market Size, Share & Trends Report

AI In Oncology Market Size, Share & Trends Analysis Report By Component (Software Solutions, Hardware, Services), By Cancer Type, By Treatment Type, By Region, And Segment Forecasts, 2022 - 2030

Report ID: GVR-4-68039-985-7
Number of Pages: 80
Format: Electronic (PDF)

Historical Range: 2016 - 2020
Industry: Healthcare

Market Segmentation

AI in Oncology Component Outlook (Revenue, USD Million, 2016 - 2030)
- Software Solutions
- Hardware
- Services
AI in Oncology Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Brain Tumor
- Others
AI in Oncology Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
- Chemotherapy
- Radiotherapy
- Immunotherapy
- Others
AI in Oncology Regional Outlook (Revenue, USD Million, 2016 - 2030)
- North America
  - North America Component Outlook (Revenue, USD Million, 2016 - 2030)
    - Software Solutions
    - Hardware
    - Services
  - North America Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
    - Breast Cancer
    - Lung Cancer
    - Prostate Cancer
    - Colorectal Cancer
    - Brain Tumor
    - Others
  - North America Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
    - Chemotherapy
    - Radiotherapy
    - Immunotherapy
    - Others
  - U.S.
    - U.S. Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - U.S. Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - U.S. Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
  - Canada
    - Canada Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - Canada Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - Canada Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
- Europe
  - Europe Component Outlook (Revenue, USD Million, 2016 - 2030)
    - Software Solutions
    - Hardware
    - Services
  - Europe Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
    - Breast Cancer
    - Lung Cancer
    - Prostate Cancer
    - Colorectal Cancer
    - Brain Tumor
    - Others
  - Europe Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
    - Chemotherapy
    - Radiotherapy
    - Immunotherapy
    - Others
  - Germany
    - Germany Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - Germany Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - Germany Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
  - U.K.
    - U.K. Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - U.K. Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - U.K. Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
  - France
    - France Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - France Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - France Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
  - Italy
    - Italy Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - Italy Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - Italy Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
  - Spain
    - Spain Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - Spain Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - Spain Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
  - Russia
    - Russia Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - Russia Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - Russia Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
- Asia Pacific
  - Asia Pacific Component Outlook (Revenue, USD Million, 2016 - 2030)
    - Software Solutions
    - Hardware
    - Services
  - Asia Pacific Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
    - Breast Cancer
    - Lung Cancer
    - Prostate Cancer
    - Colorectal Cancer
    - Brain Tumor
    - Others
  - Asia Pacific Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
    - Chemotherapy
    - Radiotherapy
    - Immunotherapy
    - Others
  - Japan
    - Japan Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - Japan Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - Japan Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
  - China
    - China Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - China Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - China Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
  - India
    - India Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - India Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - India Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
  - Australia
    - Australia Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - Australia Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - Australia Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
  - South Korea
    - South Korea Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - South Korea Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - South Korea Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
- Latin America
  - Latin America Component Outlook (Revenue, USD Million, 2016 - 2030)
    - Software Solutions
    - Hardware
    - Services
  - Latin America Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
    - Breast Cancer
    - Lung Cancer
    - Prostate Cancer
    - Colorectal Cancer
    - Brain Tumor
    - Others
  - Latin America Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
    - Chemotherapy
    - Radiotherapy
    - Immunotherapy
    - Others
  - Brazil
    - Brazil Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - Brazil Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - Brazil Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
  - Mexico
    - Mexico Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - Mexico Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - Mexico Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
  - Argentina
    - Argentina Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - Argentina Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - Argentina Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
- MEA
  - MEA Component Outlook (Revenue, USD Million, 2016 - 2030)
    - Software Solutions
    - Hardware
    - Services
  - MEA Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
    - Breast Cancer
    - Lung Cancer
    - Prostate Cancer
    - Colorectal Cancer
    - Brain Tumor
    - Others
  - MEA Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
    - Chemotherapy
    - Radiotherapy
    - Immunotherapy
    - Others
  - South Africa
    - South Africa Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - South Africa Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - South Africa Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
  - Saudi Arabia
    - Saudi Arabia Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - Saudi Arabia Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - Saudi Arabia Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others
  - UAE
    - UAE Component Outlook (Revenue, USD Million, 2016 - 2030)
      - Software Solutions
      - Hardware
      - Services
    - UAE Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Breast Cancer
      - Lung Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Brain Tumor
      - Others
    - UAE Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
      - Chemotherapy
      - Radiotherapy
      - Immunotherapy
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2016 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.